Joanne T M Tan Selected Research

Joanne T M Tan Research Topics

Disease

10	Hypoxia (Hypoxemia) 03/2024 - 01/2014
9	Inflammation (Inflammations) 05/2024 - 08/2010
8	Atherosclerosis 05/2024 - 01/2011
7	Ischemia 01/2019 - 09/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2019
3	Thrombosis (Thrombus) 01/2021 - 10/2017
3	Wounds and Injuries (Trauma) 10/2018 - 05/2013
2	Necrosis 01/2022 - 01/2014
1	Pathologic Constriction (Stenosis) 01/2023
1	Atherosclerotic Plaque (Atheroma) 01/2022
1	Diabetes Complications 01/2021
1	Vascular System Injuries 01/2021
1	Hypertrophy 01/2021
1	Hyperplasia 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2021
1	Glucose Intolerance 01/2021
1	Peripheral Arterial Disease 01/2021
1	Disease Progression 12/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Pathologic Neovascularization 01/2017
1	Rheumatoid Arthritis 11/2016
1	Neoplasms (Cancer) 11/2016
1	Obesity 06/2013
1	Weight Gain 06/2013

Drug/Important Bio-Agent (IBA)

7	HDL LipoproteinsIBA 01/2022 - 01/2014
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2014
4	Messenger RNA (mRNA)IBA 03/2024 - 01/2014
4	MicroRNAs (MicroRNA)IBA 01/2023 - 12/2019
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 04/2018 - 01/2014
3	CholesterolIBA 05/2024 - 01/2022
3	ApolipoproteinsIBA 01/2022 - 01/2014
3	CC ChemokinesIBA 01/2021 - 11/2016
3	ChemokinesIBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 12/2016 - 01/2014
2	LipidsIBA 05/2024 - 01/2023
2	Angiogenic ProteinsIBA 03/2024 - 01/2017
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022 - 01/2014
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2021
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2014 - 01/2011
1	Lipoproteins (Lipoprotein)IBA 05/2024
1	CarbonIBA 05/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2023
1	Apolipoproteins E (ApoE)IBA 01/2023
1	Colchicine FDA LinkGeneric 01/2023
1	CollagenIBA 01/2023
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2022
1	Apolipoproteins AIBA 01/2022
1	apolipoprotein A-IV (apolipoprotein AIV)IBA 01/2022
1	baysilon (polydimethylsiloxane)IBA 01/2022
1	erucylphosphocholineIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	N-propionylprocainamideIBA 01/2021
1	MetalsIBA 01/2021
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	ThioredoxinsIBA 01/2019
1	Fenofibrate (CiL)FDA LinkGeneric 01/2019
1	p38 Mitogen-Activated Protein KinasesIBA 01/2018
1	P-SelectinIBA 10/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2016
1	AndrogensIBA 12/2016
1	Streptozocin (Streptozotocin)FDA Link 10/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2016
1	Neutralizing AntibodiesIBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Ligases (Synthetase)IBA 01/2014
1	Conditioned Culture MediaIBA 01/2014
1	UbiquitinIBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014
1	matrigelIBA 01/2014
1	Insulin (Novolin)FDA Link 06/2013
1	Connective Tissue Growth FactorIBA 06/2013
1	oxidized low density lipoproteinIBA 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2011
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2011
1	LectinsIBA 01/2011
1	IonsIBA 08/2010

Therapy/Procedure

6	Therapeutics 05/2024 - 11/2016
2	Drug-Eluting Stents 01/2021 - 04/2018
2	Stents 01/2021 - 10/2017
2	Surgical Amputation (Amputations) 01/2019 - 09/2016
1	Precision Medicine 12/2019
1	Transplantation 12/2016
1	Splints (Splint) 05/2013